-
81
-
82
Association of blood cadmium and physical activity with mortality: A prospective cohort study
Published 2025-01-01Get full text
Article -
83
-
84
-
85
-
86
TClC effectively suppresses the growth and metastasis of NSCLC via polypharmacology
Published 2025-03-01Get full text
Article -
87
Protocol for engineering bone organoids from mesenchymal stem cells
Published 2025-03-01Get full text
Article -
88
-
89
Artificial intelligence links CT images to pathologic features and survival outcomes of renal masses
Published 2025-02-01Get full text
Article -
90
-
91
NSUN5 Facilitates Hepatocellular Carcinoma Progression by Increasing SMAD3 Expression
Published 2025-01-01Get full text
Article -
92
-
93
Solid Self-Microemulsifying Drug Delivery System for Improved Oral Bioavailability of Relugolix: Preparation and Evaluation
Published 2025-01-01“…Zi-Lin Li,1,* Guo-Xing Deng,1,* Chuan-Zhou Fang,1,* Yue-Qi Zhao,1 Jing Yuan,2 Liang Chen,3 Hai-Jun Zhong,1 Feng Guo1 1School of Pharmacy, Jiangxi Medical College, Nanchang University, Nanchang, 330006, People’s Republic of China; 2College of Basic Medicine and Forensic Medicine, Henan University of Science and Technology, Luoyang, 471000, People’s Republic of China; 3Jiangxi Prozin Pharmaceutical Co., LTD, Jian, 343100, People’s Republic of China*These authors contributed equally to this workCorrespondence: Feng Guo; Hai-JunZhong, School of Pharmacy, Jiangxi Medical College, Nanchang University, Nanchang, 330006, People’s Republic of China, Tel +86 0791 86361839, Email fengguo@ncu.edu.cn; zhonghj@ncu.edu.cnPurpose: To improve the oral absorption of relugolix (RLGL), which has low oral bioavailability due to its low solubility and being a substrate of P-glycoprotein (P-gp). …”
Get full text
Article